Retail Marijuana Stock Valuations Hit Decade Lows—Time to Buy?

By Sheeba M. | June 06, 2026

TL;DR: Major U.S. cannabis retailers now trade below 2016 valuation multiples despite substantially higher revenues and profitability. Margin expansion cycle creates potential 25-40% upside for disciplined operators.

The cannabis retail sector has hit a valuation inflection point. After years of overexpectation and subsequent disappointment, the market is finally repricing cannabis stocks based on actual cash generation—not future promises.

The Valuation Disconnect

Curaleaf (CURLF), the largest U.S. cannabis retailer by revenue, trades at just 6.2x forward EBITDA. Compare that to:

Trulieve (TCNNF): 5.8x forward EBITDA—the lowest in the Big Five
Green Thumb Industries (GTBIF): 7.1x forward EBITDA
Cresco Labs (CRLBF): 6.4x forward EBITDA
Verano Holdings (VRNO): 6.9x forward EBITDA

For context: U.S. specialty retail trades at 8-12x forward EBITDA. Comparable convenience retailers like Casey’s General Stores trade at 10.5x. Cannabis retailers are fundamentally undervalued.

Why the Discount Persists

Three factors drive the disconnect:

Regulatory Uncertainty: Federal Schedule III reclassification remains uncertain. Until it happens, institutional capital stays cautious.
Debt Overhang: Many retailers carry legacy debt from the financing bubble (2019-2021). Balance sheet repair consumes cash flow.
Market Saturation: Retail density in mature markets (California, Colorado, Illinois) has compressed margins for weaker operators. Only operators with scale are winning.

The Margin Inflection

Trulieve and Green Thumb demonstrated something critical in Q1 2026: scale-based margin expansion is real. TCNNF posted 22% adjusted EBITDA margins—a 300-basis-point jump from Q4 2025. GTBIF hit 19%.

These aren’t anomalies. They reflect three structural shifts:

Market consolidation weeding out weak operators
Supply normalization reducing product costs
Retail density optimization (closing unprofitable stores, expanding winning format)

As margin expansion accelerates through H2 2026, cash generation will surprise to the upside. Debt paydown accelerates. Valuations re-rate higher.

Which Retailers to Watch

Cresco Labs (CRLBF): Best-in-class wholesale distribution network outside of retail. Trading at 6.4x EBITDA with 15%+ growth and margin tailwinds.

Verano Holdings (VRNO): Highest-quality retail portfolio. Conservative balance sheet. Currently most attractive risk/reward at 6.9x forward multiples.

The next 12 months will validate whether this margin inflection is durable. If it is, cannabis retail multiples re-rate to 10-12x EBITDA—implying 25-40% upside for existing holders.

Sources

Track cannabis stocks with the Weedstock Real-Time Tracker

Retail Marijuana Stock Valuations Hit Decade Lows—Time to Buy?